1
|
Carrard A and Pichler C: House dust mite
allergy. Ther Umsch. 69:249–252. 2012.(In German).
|
2
|
Barnes PJ: New drugs for asthma. Semin
Respir Crit Care Med. 33:685–694. 2012. View Article : Google Scholar
|
3
|
Wang CM and Chuang JJ: Effect of mite
allergen immunotherapy on the altered phenotype of dendritic cells
in allergic asthmatic children. Ann Allergy Asthma Immunol.
110:107–112. 2013. View Article : Google Scholar : PubMed/NCBI
|
4
|
Maazi H, Shirinbak S, Willart M, et al:
Contribution of regulatory T cells to alleviation of experimental
allergic asthma after specific immunotherapy. Clin Exp Allergy.
42:1519–1528. 2012. View Article : Google Scholar : PubMed/NCBI
|
5
|
Eifan AO, Akkoc T, Yildiz A, Keles S,
Ozdemir C, Bahceciler NN and Barlan IB: Clinical efficacy and
immunological mechanisms of sublingual and subcutaneous
immunotherapy in asthmatic/rhinitis children sensitized to house
dust mite: an open randomized controlled trial. Clin Exp Allergy.
40:922–932. 2010. View Article : Google Scholar
|
6
|
Blumberga G, Groes L and Dahl R:
SQ-standardized house dust mite immunotherapy as an
immunomodulatory treatment in patients with asthma. Allergy.
66:178–185. 2011. View Article : Google Scholar : PubMed/NCBI
|
7
|
The Breathing Group of Pediatric Academy
affiliated to Chinese Medical Association and the Editorial Board
of Chinese Journal of Pediatrics affiliated to Chinese Medical
Association. The routine for prevention and treatment of bronchial
asthma in children (for trial). Zhonghua Er Ke Za Zhi. 42:100–106.
2004.(In Chinese).
|
8
|
Yang BZ, Chen HB, Hou JM, et al: Clinical
analysis on 520 children with bronchial asthma of allergens by skin
prick test. Journal of North Sichuan Medical College. 26:331–333.
2011.(In Chinese).
|
9
|
Akdis CA and Akdis M: Mechanisms of
allergen-specific immunotherapy. J Allergy Clin Immunol. 127:18–27.
2011. View Article : Google Scholar : PubMed/NCBI
|
10
|
Han J, Huang Y and Wang MK: Influence of
specific immunotherapy on Dermatophagoides
pteronyssinus-specific IgG4 and pulmonary function in children
suffering from allergic asthma. Journal of Third Military Medical
University. 33:618–620. 2011.(In Chinese).
|
11
|
Cox L, Calderón M and Pfaar O:
Subcutaneous allergen immunotherapy for allergic disease: examining
efficacy, safety and cost-effectiveness of current and novel
formulations. Immunotherapy. 4:601–616. 2012. View Article : Google Scholar : PubMed/NCBI
|
12
|
Gonzales M, Fratianni C, Mamillapali C and
Khardori R: Immunotherapy in miscellaneous medical disorders Graves
ophthalmopathy, asthma, and regional painful syndrome. Med Clin
North Am. 96:635–654. 2012. View Article : Google Scholar : PubMed/NCBI
|
13
|
Trebuchon F, David M and Demoly P: Medical
management and sublingual immunotherapy practices in patients with
house dust mite-induced respiratory allergy: a retrospective,
observational study. Int J Immunopathol Pharmacol. 25:193–206.
2012.
|
14
|
Hedlin G and van Hage M: The role of
immunotherapy in the management of childhood asthma. Ther Adv
Respir Dis. 6:137–146. 2012. View Article : Google Scholar : PubMed/NCBI
|
15
|
La Rosa M, Lionetti E, Leonardi S, et al:
Specific immunotherapy in children: the evidence. Int J
Immunopathol Pharmacol. 24:69–78. 2011.PubMed/NCBI
|
16
|
Stelmach I, Sobocińska A, Majak P, Smejda
K, Jerzyńska J and Stelmach W: Comparison of the long-term efficacy
of 3- and 5-year house dust mite allergen immunotherapy. Ann
Allergy Asthma Immunol. 109:274–278. 2012.PubMed/NCBI
|
17
|
Eifan AO, Shamji MH and Durham SR:
Long-term clinical and immunological effects of allergen
immunotherapy. Curr Opin Allergy Clin Immunol. 11:586–593. 2011.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Klimek L, Mewes T, Wolf H, Hansen I,
Schnitker J and Mann WJ: The effects of short-term immunotherapy
using molecular standardized grass and rye allergens compared with
symptomatic drug treatment on rhinoconjunctivitis symptoms, skin
sensitivity, and specific nasal reactivity. Otolaryngol Head Neck
Surg. 133:538–543. 2005. View Article : Google Scholar
|
19
|
Creticos PS: The consideration of
immunotherapy in the treatment of allergic asthma. J Allergy Clin
Immunol. 105:S559–S574. 2000. View Article : Google Scholar : PubMed/NCBI
|
20
|
Frew AJ: 25. Immunotherapy of allergic
disease. J Allergy Clin Immunol. 111(Suppl 2): S712–S719. 2003.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Mellerup MT, Hahn GW, Poulsen LK and
Malling H: Safety of allergen-specific immunotherapy. Relation
between dosage regimen, allergen extract, disease and systemic
side-effects during induction treatment. Clin Exp Allergy.
30:1423–1429. 2000. View Article : Google Scholar
|